dc.creatorCocks, K.
dc.creatorKing, M. T.
dc.creatorVelikova, G.
dc.creatorde Castro, G., Jr.
dc.creatorSt-James, M. Martyn
dc.creatorFayers, P. M.
dc.creatorBrown, J. M.
dc.date.accessioned2013-10-29T16:36:47Z
dc.date.accessioned2018-07-04T16:06:14Z
dc.date.available2013-10-29T16:36:47Z
dc.date.available2018-07-04T16:06:14Z
dc.date.created2013-10-29T16:36:47Z
dc.date.issued2013-08-02
dc.identifierEUROPEAN JOURNAL OF CANCER, OXFORD, v. 48, n. 11, supl. 1, Part 2, pp. 1713-1721, JUL, 2012
dc.identifier0959-8049
dc.identifierhttp://www.producao.usp.br/handle/BDPI/36608
dc.identifier10.1016/j.ejca.2012.02.059
dc.identifierhttp://dx.doi.org/10.1016/j.ejca.2012.02.059
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1631453
dc.description.abstractAim: To use published literature and experts' opinion to investigate the clinical meaning and magnitude of changes in the Quality of Life (QOL) of groups of patients measured with the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30). Methods: An innovative method combining systematic review of published studies, expert opinions and meta-analysis was used to estimate large, medium, and small mean changes over time for QLQ-C30 scores. Results: Nine hundred and eleven papers were identified, leading to 118 relevant papers. One thousand two hundred and thirty two mean changes in QOL over time were combined in the meta-analysis, with timescales ranging from four days to five years. Guidelines were produced for trivial, small, and medium size classes, for each subscale and for improving and declining scores separately. Estimates for improvements were smaller than respective estimates for declines. Conclusions: These guidelines can be used to aid sample size calculations and interpretation of mean changes over time from groups of patients. Observed mean changes in the QLQ-C30 scores are generally small in most clinical situations, possibly due to response shift. Careful consideration is needed when planning studies where QOL changes over time are of primary interest; the timing of follow up, sample attrition, direction of QOL changes, and subscales of primary interest are key considerations. (C) 2012 Elsevier Ltd. All rights reserved.
dc.languageeng
dc.publisherELSEVIER SCI LTD
dc.publisherOXFORD
dc.relationEUROPEAN JOURNAL OF CANCER
dc.rightsCopyright ELSEVIER SCI LTD
dc.rightsclosedAccess
dc.subjectEORTC QLQ-C30
dc.subjectSTATISTICAL DATA INTERPRETATION
dc.subjectQUALITY OF LIFE
dc.subjectLONGITUDINAL STUDIES
dc.subjectMEANINGFUL DIFFERENCE
dc.subjectMINIMALLY IMPORTANT DIFFERENCE
dc.subjectSAMPLE SIZE
dc.titleEvidence-based guidelines for interpreting change scores for the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución